Clinical Trial Update: Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, cisplatin, and dexamethasone in patients with relapsed or refractory Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Decadron (Dexamethasone)
• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED